BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260625T130000
DTEND;TZID=Europe/Brussels:20260625T140000
DTSTAMP:20260622T132339Z
CREATED:20260622T132337Z
LAST-MODIFIED:20260622T132339Z
UID:9699-1782392400-1782396000@www.europabio.org
SUMMARY:Preparing for scale: industrial readiness and infrastructure access
DESCRIPTION:APROVALS Webinar Series – Public Session \n\n\n\nThis is the first session of the APROVALS public webinar series\, a programme of collective learning events open to companies participating in the project and to the broader industrial ecosystem. \n\n\n\nAPROVALS webinars are designed to go beyond individual sandbox sessions: they create a shared space where companies can compare experiences\, discuss cross-cutting challenges\, and engage with external experts on the topics that matter most to scaling innovative technologies. \n\n\n\nSession #1 – Preparing for scale: industrial readiness and infrastructure access \n\n\n\nOne of the most strategic — and most frequently asked — questions among APROVALS participants: how do you know when you are ready to move from pilot to industrial scale? \n\n\n\nThis session will explore: \n\n\n\n\nThe key signals and criteria that indicate readiness for industrialisation\n\n\n\nCommon bottlenecks companies face when scaling from lab or pilot to full production\n\n\n\nFrameworks and options available to navigate this transition in a structured way\n\n\n\n\nWe’ll discuss with: \n\n\n\nRob Kooijmans (Food Safety) \n\n\n\nReza Ranjbar (AartinBio) \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/preparing-for-scale-industrial-readiness-and-infrastructure-access/
CATEGORIES:External,Industrial Biotech,National Associations,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/06/Event-Banners-Website-6.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260701T093000
DTEND;TZID=Europe/Brussels:20260701T133000
DTSTAMP:20260519T114509Z
CREATED:20260505T073147Z
LAST-MODIFIED:20260519T114509Z
UID:9589-1782898200-1782912600@www.europabio.org
SUMMARY:EuropaBio Biomanufacturing Policy Summit 2026
DESCRIPTION:From legislation to impact for Europe \n\n\n\nBiomanufacturing lies at the heart of Europe’s future societal and entrepreneurial strength and is changing the business landscape for both emerging innovators and established industry champions. \n\n\n\nEuropaBio’s 4th Biomanufacturing Policy Summit will focus on how legislation delivers impact within a proactive Biomanufacturing strategy\, and how we establish EU targets for outcomes. It will also showcase the 2026 update of the EuropaBio WIfoR study ‘Measuring the Economic Footprint of the Biotechnology Industry in the European Union’ prior to full report launch in September. \n\n\n\nThe prize is globally competitive multi-sector biomanufacturing\, keeping pace with industrial transition in major global regions and securing Europe’s supply chains\, healthcare future\, decarbonisation and economic resilience. \n\n\n\nThis meeting will bring together EuropaBio Members\, representatives of key sectors\, plus national and EU stakeholders across institutions. \n\n\n\nThis event will be accessible by invitation only\, for more information contact us at: communications@europabio.org and c.skentelbery@europabio.org
URL:https://www.europabio.org/event/europabio-biomanufacturing-policy-summit-2026/
CATEGORIES:Biomanufacturing Platform,EuropaBio,Healthcare Biotech,Industrial Biotech,National Associations,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/05/Event-Banner-EuropaBio-Biomanufacturing-Policy-Summit-2026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260713T100000
DTEND;TZID=Europe/Brussels:20260713T110000
DTSTAMP:20260703T110803Z
CREATED:20260615T074916Z
LAST-MODIFIED:20260703T110803Z
UID:9672-1783936800-1783940400@www.europabio.org
SUMMARY:EFIB Den Haag Statement - A modernised European Union for Industrial Biotechnology
DESCRIPTION:EuropaBio’s EFIB Statement presents three clear asks for the European Union: \n\n\n\nAsk 1 – Modernising regulation and policy: A dedicated\, horizontal EU Regulation for Microorganisms \n\n\n\nAsk 2 – Education and awareness: Future-looking stakeholder engagement and Representation \n\n\n\nAsk 3 – Financing innovation: Delivering a mature funding and collaborative framework \n\n\n\nThese asks sit within a progressive legislative mandate for industrial biotechnology and microorganisms. It supports the translation of a competitiveness agenda into legislation that delivers the bioeconomy. \n\n\n\nJoin EuropaBio for a deep dive into the EFIB Statement and what it means for innovation and manufacturing in the European Union? \n\n\n\nAGENDA \n\n\n\nPresentation of the EFIB statement: Claire Skentelbery\, Director General\, EuropaBio \n\n\n\nFireside chat: Giovanni Colombo\, Group Senior Director Public Affairs\, dsm-firmenich and Board Member EuropaBio \n\n\n\n\nRegister Here
URL:https://www.europabio.org/event/efib-den-haag-statement-a-modernised-european-union-for-industrial-biotechnology/
CATEGORIES:EFIB,EuropaBio,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/06/EFIB-2026-Den-Haag-Statement-Event-Banner-Website-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260923T080000
DTEND;TZID=Europe/Brussels:20260923T200000
DTSTAMP:20260413T122833Z
CREATED:20260413T122644Z
LAST-MODIFIED:20260413T122833Z
UID:9571-1790150400-1790193600@www.europabio.org
SUMMARY:Prague.bio Conference 2026
DESCRIPTION:Join our Director General Dr Claire Skentelbery at the 4th edition of Prague.bio Conference! \n\n\n\nIf you want to meet and network with biotech leaders shaping the CEE region\, Prague.bio Conference 2026 is the place to be \n\n\n\nExpect 400+ participants\, partnering via the conference app\, inspiring keynotes\, panel discussions\, hands-on workshops\, and pitch & poster sessions. \n\n\n\n \n\n\n\n\nMore Info Here & Tickets
URL:https://www.europabio.org/event/prague-bio-conference-2026/
CATEGORIES:External,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/04/Event-Banners-Website-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260930T110000
DTEND;TZID=Europe/Brussels:20260930T133000
DTSTAMP:20260901T091358Z
CREATED:20260901T091316Z
LAST-MODIFIED:20260901T091358Z
UID:9749-1790766000-1790775000@www.europabio.org
SUMMARY:Draghi Needs Friends - How to Keep Biotech Scaling in Europe
DESCRIPTION:Hosted by Regina Doherty MEP (EPP\, Ireland). Organised by BioPharmaChem Ireland and EuropaBio \n\n\n\nWhy now. European biotech companies still cross the Atlantic to scale; for late-stage capital\, for listings\, or through an acquisition that arrives too early. Meanwhile\, the competition is moving. China’s 15th Five-Year Plan for 2026 to 2030 names life science and biotechnology among eight frontier technologies targeted for breakthrough\, identifies biomanufacturing as a priority for industrial upgrading\, and sets a research and development expenditure target above 3.2% of gross domestic product.The European political framework is open at the same time. The Biotech Act is in negotiation as two instruments\, a Regulation and a Directive\, both tabled in December 2025. EU Inc. was proposed in March 2026\, and the Commission is urging Parliament and Council to agree by the end of 2026. On the financing side\, Europe is still working in delivering the Savings and Investments Union and negotiating the next Multi-Financial Framework. Biotech Act II\, covering industrial biotechnology and biomanufacturing\, follows. \n\n\n\nSession 1\, 11.05 to 11.50 – The gap\, the instruments\, and what investors look for \n\n\n\nSession 2\, 12.05 to 12.50. Draghi needs friends: why are we stuck\, and what moves first? \n\n\n\nSpace for this event is limited\, therefore attendance is not guaranteed\, confirmation of attendance will be sent via email closer to the date of the event. \n\n\n\n\nRegister Interest Here
URL:https://www.europabio.org/event/draghi-needs-friends-how-to-keep-biotech-scaling-in-europe/
CATEGORIES:Biomanufacturing Platform,Biotech Week,EuropaBio,Healthcare Biotech,Industrial Biotech,National Associations,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/09/Event-Banner-Irish-Presidency-Summit.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20261006T100000
DTEND;TZID=Europe/Brussels:20261008T180000
DTSTAMP:20261006T070726Z
CREATED:20261006T070707Z
LAST-MODIFIED:20261006T070726Z
UID:9780-1791280800-1791482400@www.europabio.org
SUMMARY:CPHI Milan 2026
DESCRIPTION:EuropaBio is pleased to partner with CPHI Milan 2026. This year’s edition held from the 6th to the 10th of October in Fiera Milano\, Italy promises to a packed agenda. \n\n\n\nJoin our Director General Dr Claire Skentelbery this year where she will be giving a keynote on the 7th of October. \n\n\n\n\nFind Out More & Register Here
URL:https://www.europabio.org/event/cphi-milan-2026/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/10/Event-Banners-Website-8.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20261026T080000
DTEND;TZID=Europe/Brussels:20261028T200000
DTSTAMP:20260219T132456Z
CREATED:20260219T132453Z
LAST-MODIFIED:20260219T132456Z
UID:9482-1793001600-1793217600@www.europabio.org
SUMMARY:World Orphan Drug Congress 2026
DESCRIPTION:The World Orphan Drug Congress Europe is the largest and most established event globally for orphan drugs and rare diseases. \n\n\n\nJoin over 1\,800 senior industry leaders\, gain insights from 250+ expert speakers\, and connect with over 100 exhibitors driving progress across the entire orphan drug lifecycle. From regulatory strategy and market access to patient engagement and the latest breakthroughs in gene and cell therapies\, the congress delivers practical insights you can apply immediately. \n\n\n\nNetwork with the most senior individuals across the industry\, including leaders in R&D\, gene therapy\, rare diseases\, precision/personalised medicine\, genetic disorders\, patient advocacy and engagement\, associations in ATMPs\, investors\, regulatory affairs professions\, governmental bodies\, and more… \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/world-orphan-drug-congress-2026/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/02/Event-Banners-Website-42.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20261109T080000
DTEND;TZID=Europe/Brussels:20261111T200000
DTSTAMP:20261006T072502Z
CREATED:20261006T072501Z
LAST-MODIFIED:20261006T072502Z
UID:9788-1794211200-1794427200@www.europabio.org
SUMMARY:BIO Europe 2026
DESCRIPTION:Where the global community of biopharma C‑suite\, investors and partners meet to navigate complexity\, forge the connections that matter\, and accelerate the path from innovation to impact. \n\n\n\nJoin our Director General\, Dr Claire Skentelbery at this years edition of BIO Europe in Germany! \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/bio-europe-2026/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/10/Event-Banners-Website-9.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20261124T080000
DTEND;TZID=Europe/Brussels:20261125T200000
DTSTAMP:20261006T075616Z
CREATED:20261006T075615Z
LAST-MODIFIED:20261006T075616Z
UID:9790-1795507200-1795636800@www.europabio.org
SUMMARY:FEBIO - FutureEatsBiotech Valencia
DESCRIPTION:Join our Director General\, Dr Claire Skentelbery in Valencia for FutureEatsBiotech Valencia on the 24th and 25th of November where she will be speaking about Food Biotechnology and Biomanufacturing. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/febio-futureeatsbiotech-valencia/
CATEGORIES:Biomanufacturing Platform,External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/10/Event-Banners-Website-10.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20261210T080000
DTEND;TZID=Europe/Brussels:20261210T200000
DTSTAMP:20261006T081053Z
CREATED:20261006T081052Z
LAST-MODIFIED:20261006T081053Z
UID:9793-1796889600-1796932800@www.europabio.org
SUMMARY:Genesis 2026
DESCRIPTION:For more than two decades\, Genesis has united key opinion leaders\, R&D innovators\, investors\, and industry stakeholders to discuss trends\, initiate partnerships\, and elevate breakthrough science. \n\n\n\nJoin our Director General\, Dr Claire Skentelbery in London for Genesis 2026 on the 10th of December where she will be speaking in Keynote Panel 1: How Can You Scale a UK Biotech Without Selling Out to a Richer International Counterpart? \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/genesis-2026/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech,Industrial Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/10/Event-Banners-Website-11.png
END:VEVENT
END:VCALENDAR